3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Myelodysplastic Syndromes
17
Multiple Myeloma
12
Ovarian Neoplasms
9
Recurrence
8
Lymphoma, B-Cell
8
Pancreatic Neoplasms
7
Lymphoma, Non-Hodgkin
7
Lymphoma
7
Hodgkin Disease
7
Burkitt Lymphoma
7
Colorectal Neoplasms
6
Myeloproliferative Disorders
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia, Biphenotypic, Acute
5
Stomach Neoplasms
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia
4
Hematologic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urogenital Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Osteosarcoma
3
Melanoma
3
Lymphoma, Follicular
3
Leukemia, B-Cell
3
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Camurati-Engelmann Syndrome
×
fludarabine
×
30 days
×
Clear all
No trials found.